文献速递糖尿病

具有个体化预防干预效果的糖尿病风险预测模型的开发与验证

Development and Validation of a Diabetes Risk Prediction Model With Individualized Preventive Intervention Effects.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

研究基于糖尿病预防计划(DPP)试验中随机接受安慰剂、二甲双胍或强化生活方式干预的2640名参与者开发了2型糖尿病风险预测模型,并在多种族动脉粥样硬化研究(MESA)的2104名糖尿病前期参与者中外部验证。模型纳入性别、糖化血红蛋白、空腹血糖、体质指数、甘油三酯及干预方式,并包含干预与年龄、空腹血糖、体质指数的交互项以生成个体化干预效果。DPP中平均C统计量为0.71(95%CI:0.68,0.74),MESA中为0.86(95%CI:0.83,0.88),最优预防干预(3年风险最低)在DPP和MESA中分别为86%和97%的参与者为生活方式干预,其余为二甲双胍。

要点

  • 模型基于DPP试验2640名参与者开发,纳入性别、糖化血红蛋白、空腹血糖、体质指数、甘油三酯及干预方式。
  • DPP内部验证平均C统计量0.71(95%CI:0.68,0.74),MESA外部验证0.86(95%CI:0.83,0.88)。
  • 最优预防干预(3年风险最低)在DPP中86%、MESA中97%的参与者为生活方式干预,其余为二甲双胍。

核心结论

  • 这是首个开发并验证具有个体化预防干预效果的糖尿病风险预测模型的研究,该模型可能改善临床决策和糖尿病预防。

研究设计与样本

  • 推导队列为糖尿病预防计划(DPP)试验中随机接受安慰剂、二甲双胍或强化生活方式干预的参与者(n=2640)。
  • 采用Cox比例风险回归开发 incident diabetes 风险预测模型,纳入临床可用预测因子:性别、糖化血红蛋白、空腹血糖、体质指数、甘油三酯及干预方式。
  • 为生成个体化干预效果,纳入干预与年龄、空腹血糖、体质指数的两两交互项。
  • 在DPP内部验证模型3年预测的区分度、校准度和净获益,并在MESA的糖尿病前期参与者(n=2104)中进行外部验证。

主要发现

  • DPP和MESA中平均(标准差)年龄分别为51(11)岁和64(10)岁,女性分别占67%和50%。
  • DPP中平均C统计量为0.71(95%CI:0.68,0.74),MESA中为0.86(95%CI:0.83,0.88)。
  • 最优预防干预(3年风险最低)在DPP中86%、MESA中97%的参与者为生活方式干预,其余为二甲双胍。
  • 模型性能在不同种族/族裔组间相似。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Type 2 diabetes risk prediction models lack the option to predict risk conditional on initiating different preventive interventions. Our objective was to develop and validate a diabetes risk prediction model with individualized preventive intervention effects among racially diverse populations. METHODS: The derivation cohort included participants in the Diabetes Prevention Program (DPP) trial randomized to placebo, metformin, or intensive lifestyle intervention (n = 2640). A risk prediction model for incident diabetes was developed using Cox proportional hazards regression using clinically available predictors: sex, glycated hemoglobin, fasting plasma glucose (FPG), body mass index (BMI), triglycerides, and intervention. To create individualized intervention effects, pairwise interactions between intervention and age, FPG, and BMI were included. The discrimination, calibration, and net benefit of the model's 3-year predictions for incident diabetes were internally validated within the DPP and externally validated among participants with prediabetes in the Multi-Ethnic Study of Atherosclerosis (MESA; n = 2104). RESULTS: In DPP and MESA, mean (SD) age was 51 years (11) and 64 (10), and 67% and 50% of participants were women, respectively. The mean C-statistic was 0.71 [95% confidence interval (CI): 0.68, 0.74] in DPP and 0.86 (95% CI: 0.83, 0.88) in MESA. The optimal preventive intervention (lowest 3-year risk) was lifestyle for 86% and 97% of DPP and MESA participants, respectively, and metformin for the remaining. Model performance was similar across race/ethnicity groups. CONCLUSION: This is the first study to develop and validate a diabetes risk prediction model with individualized preventive intervention effects that may improve clinical decision-making and diabetes prevention.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Jaeger B, Casanova R, Demesie Y, et al. Development and Validation of a Diabetes Risk Prediction Model With Individualized Preventive Intervention Effects. J Clin Endocrinol Metab. 2025. PMID: 40265376. doi:10.1210/clinem/dgaf250

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。